skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Lanreotide Acetate Copolymer Microparticles (Code C53437)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Lanreotide Acetate Copolymer Microparticles

Definition: A prolonged-release depot suspension of microparticles containing the acetate salt of lanreotide, a synthetic peptide analog of the naturally occurring somatostatin, and copolymers. Lanreotide inhibits the secretion of growth hormone (GH) by binding to pituitary somatostatin receptors, and may inhibit various other hormones, including thyroid-stimulating hormone (TSH) and the gastroenteropancreatic hormones insulin, glucagon and gastrin. This agent has a much longer duration of action than natural somatostatin and is selective towards the inhibition of growth hormone.

Label: Lanreotide Acetate Copolymer Microparticles

NCI Thesaurus Code: C53437 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1708642  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Lanreotide Acetate Copolymer Microparticles
Somatuline LA

External Source Codes: 
PDQ Closed Trial Search ID 463333
PDQ Open Trial Search ID 463333 (check for NCI PDQ open clinical trial info)
UMLS CUI C1708642

Other Properties:
     Name Value (qualifiers indented underneath)
code C53437
Legacy_Concept_Name Lanreotide_Acetate_Copolymer_Microparticle
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom